US FDA warns 30 telehealth firms over misleading ads for compounded weight‑loss drugs

Investing.com Gold reports: US FDA warns 30 telehealth firms over misleading ads for compounded weight‑loss drugs. This is a premium/paywalled source, so the brief is based on headline and available metadata only.